METTL3 and pancreatic neoplasm: In addition, pancreatic cancer was also found to have upregulated METTL3 and downregulated ALKBH5 (m6A eraser) expression, and this dysregulation significantly influenced RNA methylation and resulted in poor clinical outcomes.